The aim of this study was to measure the levels of TREM-1 and HLA-DR on monocytes and the serum concentrations of IL-6 and IL-10 in patients with AP to determine whether these markers, alone or in combination, can be used in the early identification of patients at high risk of developing severe AP or infection. This evidence concerns the gene TREM1 and alkaline phosphatase measurement.